
Conference Coverage
about 1 month ago
AAOpt 2025: Fitting irregular corneasabout 1 month ago
AAOpt 2025: Heading the frontiers in eye careabout 1 month ago
AAOpt 2025: The use of multimodal imaging for retinal diseaseabout 2 months ago
What ODs and MDs learned outside their specialties at EyeCon 2025about 2 months ago
EyeCon 2025: The latest on treating ocular surface and cornea diseaseLatest Content

Reflex for stabilizing vision develops without sensory input

AFSCME 3299 members strike on UC campuses, UPTE-CWA 9119 reaches tentative agreement

Pearls outside the specialty: What optometrists gained at Academy 2025

Setting sail on the seas of eye care education: What you missed at Academy 2025

Takeaways from this week in optometry: November 10 - November 14

Shorts






Podcasts
Videos
Optometry Times Digital Edition


Continuing Medical Education
All News

Rose Mandel, OD, shares how the NYU Langone Eye Center tackles a variety of cases in day-to-day practice.

Advances address a need for the growing populace with age-related near vision loss.

In the study, authors investigated the natural history of GA lesion incidence rates and analyzed potential risk factors for faster incidence of GA lesions.

Wen, OD, gives an overview of the glaucoma landscape, from necessary technology and management options.

This retrospective cohort study used a large US administrative claims database to identify patients with a diagnosis of seborrheic dermatitis from January 1, 2016, through June 30, 2022.

Clark Chang, OD, MSA, MSc, FAAO; and Michelle Chung, OD, FAAO, FSLS, provided cornea updates during the American Academy of Optometry Academy 2025 conference.

Consider these tips for educating patients on additive, lens-based vision correction.

Catch up on the top stories in optometry during the week of November 3-November 7.

Mark Schaeffer, OD, FAAL, details his poster presentation titled "Practitioner satisfaction and experience with a novel daily disposable toric contact lens in a real-world evaluation."

Johnson & Johnson and The Contact Lens Institute were among industry leaders that provided research and study results during the conference.

A shift toward minimally invasive, evidence-based interventions is redefining standards of care.

The submission marks the first ex-US regulatory submission for Brimochol PF.

Today’s tools let clinicians fine-tune fits with accuracy, while solving old challenges and unlocking complex optical corrections.

Dry eye disease is ubiquitous, with up to 20% of middle-aged patients estimated to have moderate to severe symptoms or searching for a treatment.

The trial met its primary efficacy and key secondary end points.




































































.png)


